Enzymotec is a biotech company, which develops advanced, innovative lipid-based ingredients for the nutraceuticals and functional foods markets.
At the upcoming IFT show in New Orleans in July, Enzymotec will feature CardiaBeat™, an innovative ingredient that is targeted to reduce CVD risk factors including: “bad” cholesterol (LDL), triglycerides and oxidative stress. It can be easily applied to food applications such as: bars, dairy or spreads.
Enzymotec will also present new high grade phosphatidylserine (PS) as part of its SharpPS(TM) line.
PS is a lecithin-derived cognitive enhancer, commonly used in dietary supplements. Enzymotec can provide manufacturers with a wide range of PS solutions such as: enhanced stability, altered physical performance and other custom made solutions.
IFT: Booth # 5049